Malignant Colon Neoplasm — Trials

Malignant Colon Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,196 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 225
Recruiting: 117
Ph III recruiting: 18
Growth YoY: −3.8%
Industry share: 14%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 26.9%
Trials / 1,000 deaths: 5.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (139)

clinicaltrialsPublishedShowing 1–38 of 38 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07840677	Tafolecimab Combined With Chemoimmunotherapy as Neoadjuvant Treatment for pMMR/MSS Locally Advanced Colon Cancer(TRIUNITE-08)	recruiting	Phase 2	70	Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER	1	Sep 25, 2026	clinicaltrials
NCT07841236	ctDNA-Guided Immunotherapy for dMMR/MSI-H Colon Cancer	recruiting	Phase 2	23	Fudan UniversityOTHER	1